| Product Code: ETC10535877 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Ankylosing Spondylitis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Ankylosing Spondylitis Market Revenues & Volume, 2021 & 2031F |
3.3 China Ankylosing Spondylitis Market - Industry Life Cycle |
3.4 China Ankylosing Spondylitis Market - Porter's Five Forces |
3.5 China Ankylosing Spondylitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 China Ankylosing Spondylitis Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Ankylosing Spondylitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Ankylosing Spondylitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of ankylosing spondylitis in China |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in China |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals specializing in ankylosing spondylitis |
4.3.2 Limited availability of advanced treatments and medications |
4.3.3 High cost associated with long-term management of ankylosing spondylitis |
5 China Ankylosing Spondylitis Market Trends |
6 China Ankylosing Spondylitis Market, By Types |
6.1 China Ankylosing Spondylitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 China Ankylosing Spondylitis Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 China Ankylosing Spondylitis Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 China Ankylosing Spondylitis Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.1.5 China Ankylosing Spondylitis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.1.6 China Ankylosing Spondylitis Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 China Ankylosing Spondylitis Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Ankylosing Spondylitis Market Revenues & Volume, By Pain & Inflammation, 2021 - 2031F |
6.2.3 China Ankylosing Spondylitis Market Revenues & Volume, By Disease Management, 2021 - 2031F |
6.2.4 China Ankylosing Spondylitis Market Revenues & Volume, By Mobility Improvement, 2021 - 2031F |
6.2.5 China Ankylosing Spondylitis Market Revenues & Volume, By Severe Cases Treatment, 2021 - 2031F |
6.3 China Ankylosing Spondylitis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Ankylosing Spondylitis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Ankylosing Spondylitis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 China Ankylosing Spondylitis Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.3.5 China Ankylosing Spondylitis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 China Ankylosing Spondylitis Market Import-Export Trade Statistics |
7.1 China Ankylosing Spondylitis Market Export to Major Countries |
7.2 China Ankylosing Spondylitis Market Imports from Major Countries |
8 China Ankylosing Spondylitis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Patient adherence to treatment plans |
8.3 Number of healthcare facilities offering specialized care for ankylosing spondylitis |
8.4 Patient satisfaction with treatment outcomes |
8.5 Adoption rate of new treatment guidelines and protocols |
9 China Ankylosing Spondylitis Market - Opportunity Assessment |
9.1 China Ankylosing Spondylitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 China Ankylosing Spondylitis Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Ankylosing Spondylitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Ankylosing Spondylitis Market - Competitive Landscape |
10.1 China Ankylosing Spondylitis Market Revenue Share, By Companies, 2024 |
10.2 China Ankylosing Spondylitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here